Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT ARCUTIS BIOTHERAPEUTICS, INC.

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT)
Listen to this Section


$21.82
-0.1350 ( -0.62% ) 263.6K

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate ZORYVE roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

Market Data


Open $21.82
Previous Close $21.95
Volume 263.6K
Market Cap $2.75B
Day Range $21.77 - $22.17
52 Week Range $12.72 - $31.77
Shares Outstanding 125.08M
Change % -0.62%
Net Change ▼ -0.1350
Insider Ownership -0.03%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2020
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -110,519.00

Date Type Amount Purchased Purchaser
2025-06-17 Buy 2646.00 Heron Patrick J
2025-06-06 Buy 1890.00 Heron Patrick J
2025-05-23 Buy 2520.00 Heron Patrick J
2025-05-19 Buy 2520.00 Heron Patrick J
2025-05-15 Buy 2374.00 Heron Patrick J
2025-05-13 Buy 6300.00 Heron Patrick J
2024-12-03 Buy 1093.00 Edwards Larry Todd
2024-08-05 Sale -14487.00 Watanabe Todd Franklin
2024-08-05 Sale -5220.00 Matsuda Masaru
2024-08-05 Sale -13206.00 Burnett Patrick

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Aug 05, 2025
4 Insider transactions 1 Aug 05, 2025
4 Insider transactions 1 Aug 05, 2025
4 Insider transactions 1 Aug 05, 2025
4 Insider transactions 1 Aug 05, 2025
4 Insider transactions 3 Jul 14, 2025
4 Insider transactions 1 Jul 02, 2025
4 Insider transactions 1 Jun 20, 2025
8-k 8K-related 13 Jun 17, 2025
4 Insider transactions 1 Jun 17, 2025

Latest News


× Before browsing our site, please accept our cookies policy